Recent Updates
Recently added Catalysts

COMMODORE CAPITAL LP

Track COMMODORE CAPITAL LP's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Jun 19, 2026
Showing 6 Stocks Out Of 36. Click On The Tickers For More Details
Stock Compnay Name Shares Held Market Value % of Portfolio QoQ Change
PALI
PALI
PALISADE BIO INC
7.18 M
12.57 M
0.7
CRVS
CRVS
CORVUS PHARMACEUTICALS INC
2.26 M
33.05 M
1.9
ASMB
ASMB
ASSEMBLY BIOSCIENCES INC
1.00 M
27.75 M
1.6
CATX
CATX
PERSPECTIVE THERAPEUTICS INC
6.34 M
26.42 M
1.5
SLNO
SLNO
SOLENO THERAPEUTICS INC
652.43 K
21.84 M
1.3
OCUL
OCUL
OCULAR THERAPEUTIX INC
2.58 M
21.81 M
1.3
API Access

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real time data to maximize your biotech profits.

yearly_arrow
For Visitors

Preview only and discover why serious investors choose our Premium Plan for comprehensive data.

$0.00 / Month

  • Includes 3 day Elite access
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $24.00/ Month

  • Searchable FDA Calendar with 1000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) score cards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
Market Value

$ 1.73 B

Holdings

36

Period

Q1 2026

Holdings in Top 20

86.8 %

QoQ Changes

15.06 %

Top 20 Holdings